A new study reports for the first time that injection of neuropeptide vasoactive intestinal peptide (VIP) directly into the eye of mice enhanced corneal graft survival. A new study in the American ...
Kudo, T., Tahara, Y., Gamble, K.L., McMahon, D.G., Block, G.D., and Colwell, C.S. (2013). Vasoactive intestinal peptide produces long-lasting changes in neural ...
The study of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) has expanded markedly over recent decades, establishing these neuropeptides as pivotal ...
The neuropeptide vasoactive intestinal peptide (VIP) has been shown to inhibit macrophage proinflammatory actions, promote a positive Th2/Th1 balance, and stimulate regulatory T-cell production. The ...
Therapy with immune checkpoint inhibitors has become a new therapeutic option for several types of cancer, but immune-related adverse events can limit their use. 1 Outside of clinical studies, ...
Use of vasoactive intestinal peptide (VIP) to treat critical COVID-19 respiratory failure in patients with comorbidities has shown promise. Researchers presented findings from a prospective, ...
Please provide your email address to receive an email when new articles are posted on . Increased serum vasoactive intestinal peptide levels appeared associated with acute exacerbation of chronic ...
An international research team led by scientists from Bern and Charité—Universitätsmedizin Berlin has identified a previously unknown function of the intestinal nervous system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results